Eloxx Pharmaceuticals Inc (ELOX)
0.90
+0.06
(+7.44%)
USD |
OTCM |
May 17, 16:00
Eloxx Pharmaceuticals Enterprise Value: 3.494M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 3.494M |
| May 16, 2024 | 3.298M |
| May 15, 2024 | 3.364M |
| May 14, 2024 | 3.494M |
| May 13, 2024 | 3.494M |
| May 10, 2024 | 3.545M |
| May 09, 2024 | 3.222M |
| May 08, 2024 | 3.337M |
| May 07, 2024 | 3.368M |
| May 06, 2024 | 3.353M |
| May 03, 2024 | 3.494M |
| May 02, 2024 | 3.337M |
| May 01, 2024 | 3.431M |
| April 30, 2024 | 3.686M |
| April 29, 2024 | 3.526M |
| April 26, 2024 | 3.198M |
| April 25, 2024 | 3.133M |
| April 24, 2024 | 3.211M |
| April 23, 2024 | 3.258M |
| April 22, 2024 | 3.188M |
| April 19, 2024 | 3.183M |
| April 18, 2024 | 3.620M |
| April 17, 2024 | 3.690M |
| April 16, 2024 | 3.769M |
| April 15, 2024 | 3.746M |
| Date | Value |
|---|---|
| April 12, 2024 | 3.871M |
| April 11, 2024 | 3.746M |
| April 10, 2024 | 3.840M |
| April 09, 2024 | 3.934M |
| April 08, 2024 | 3.934M |
| April 05, 2024 | 3.808M |
| April 04, 2024 | 4.028M |
| April 03, 2024 | 4.091M |
| April 02, 2024 | 3.808M |
| April 01, 2024 | 3.871M |
| March 28, 2024 | 3.808M |
| March 27, 2024 | 3.494M |
| March 26, 2024 | 3.337M |
| March 25, 2024 | 3.494M |
| March 22, 2024 | 3.529M |
| March 21, 2024 | 3.651M |
| March 20, 2024 | 3.871M |
| March 19, 2024 | 3.683M |
| March 18, 2024 | 4.028M |
| March 15, 2024 | 4.123M |
| March 14, 2024 | 3.966M |
| March 13, 2024 | 3.840M |
| March 12, 2024 | 3.518M |
| March 11, 2024 | 3.651M |
| March 08, 2024 | 3.438M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-8.305M
Minimum
Dec 28 2022
359.09M
Maximum
Jun 27 2019
70.05M
Average
34.35M
Median
Nov 17 2021
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 5.156M |
| Palatin Technologies Inc | 22.26M |
| iBio Inc | 16.77M |
| Theriva Biologics Inc | -8.901M |
| Oragenics Inc | 8.862M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.592M |
| Total Expenses (Quarterly) | 3.637M |
| EPS Diluted (Quarterly) | -1.31 |
| Earnings Yield | -1.01K% |
| Normalized Earnings Yield | -24678.22 |